C. Prost‐Squarcioni

4.3k total citations
50 papers, 1.2k citations indexed

About

C. Prost‐Squarcioni is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, C. Prost‐Squarcioni has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pathology and Forensic Medicine, 24 papers in Genetics and 23 papers in Rheumatology. Recurrent topics in C. Prost‐Squarcioni's work include Autoimmune Bullous Skin Diseases (40 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (23 papers) and Urticaria and Related Conditions (22 papers). C. Prost‐Squarcioni is often cited by papers focused on Autoimmune Bullous Skin Diseases (40 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (23 papers) and Urticaria and Related Conditions (22 papers). C. Prost‐Squarcioni collaborates with scholars based in France, United States and Germany. C. Prost‐Squarcioni's co-authors include F. Caux, M. Alexandre, Françoise Aucouturier, C. Le Roux‐Villet, Serge Doan, L. Laroche, Hiroshi Koga, Ralf J. Ludwig, Hiroaki Iwata and Sylvie Fraitag and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Free Radical Biology and Medicine.

In The Last Decade

C. Prost‐Squarcioni

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Prost‐Squarcioni France 20 753 583 531 160 152 50 1.2k
Hironori Niizeki Japan 18 342 0.5× 149 0.3× 309 0.6× 132 0.8× 101 0.7× 52 1.0k
Johannes S. Kern Germany 24 814 1.1× 360 0.6× 336 0.6× 430 2.7× 244 1.6× 83 2.0k
Fabienne Jaunin Switzerland 15 378 0.5× 277 0.5× 301 0.6× 160 1.0× 25 0.2× 17 967
Ken Ishii Japan 24 1.6k 2.1× 1.1k 2.0× 1.1k 2.0× 186 1.2× 30 0.2× 38 2.1k
Dimitra Kiritsi Germany 26 622 0.8× 165 0.3× 152 0.3× 617 3.9× 258 1.7× 80 1.9k
John R. Schiltz United States 12 361 0.5× 214 0.4× 252 0.5× 189 1.2× 40 0.3× 18 721
Sho Hiroyasu Canada 14 213 0.3× 158 0.3× 170 0.3× 133 0.8× 22 0.1× 25 577
Tiago R. Matos United States 16 233 0.3× 241 0.4× 51 0.1× 185 1.2× 46 0.3× 32 1.5k
Ramzy S. Labib United States 23 3.0k 4.0× 2.0k 3.5× 1.7k 3.3× 189 1.2× 68 0.4× 38 3.5k
A M Irani United States 17 71 0.1× 274 0.5× 424 0.8× 413 2.6× 40 0.3× 18 2.1k

Countries citing papers authored by C. Prost‐Squarcioni

Since Specialization
Citations

This map shows the geographic impact of C. Prost‐Squarcioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Prost‐Squarcioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Prost‐Squarcioni more than expected).

Fields of papers citing papers by C. Prost‐Squarcioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Prost‐Squarcioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Prost‐Squarcioni. The network helps show where C. Prost‐Squarcioni may publish in the future.

Co-authorship network of co-authors of C. Prost‐Squarcioni

This figure shows the co-authorship network connecting the top 25 collaborators of C. Prost‐Squarcioni. A scholar is included among the top collaborators of C. Prost‐Squarcioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Prost‐Squarcioni. C. Prost‐Squarcioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohelay, G., M. Alexandre, C. Le Roux‐Villet, et al.. (2022). Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients. Frontiers in Immunology. 13. 915205–915205. 9 indexed citations
2.
Gillibert, André, S. Duvert‐Lehembre, M. Alexandre, et al.. (2020). Sensitivity to change and correlation between the autoimmune bullous disease quality‐of‐life questionnaires ABQOL and TABQOL , and objective severity scores. British Journal of Dermatology. 183(5). 944–945. 8 indexed citations
3.
Rousseau, Antoine, C. Prost‐Squarcioni, Serge Doan, et al.. (2019). Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up. British Journal of Ophthalmology. 104(2). 235–240. 7 indexed citations
4.
Yatim, Ahmad, G. Bohelay, S. Grootenboer‐Mignot, et al.. (2019). Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa. Frontiers in Medicine. 6. 249–249. 19 indexed citations
5.
Prost‐Squarcioni, C., F. Tétart, Benoît Bensaïd, et al.. (2018). Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases. British Journal of Clinical Pharmacology. 85(3). 570–579. 39 indexed citations
6.
7.
Iwata, Hiroaki, Artem Vorobyev, Hiroshi Koga, et al.. (2018). Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. Orphanet Journal of Rare Diseases. 13(1). 153–153. 49 indexed citations
8.
Prost‐Squarcioni, C., F. Caux, Enno Schmidt, et al.. (2017). International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. British Journal of Dermatology. 179(1). 30–41. 45 indexed citations
9.
Gottlieb, J., S. Oro, M. Alexandre, et al.. (2016). Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. British Journal of Dermatology. 177(1). 212–222. 34 indexed citations
10.
Gaultier, Frédérick, C. Prost‐Squarcioni, Philippe Bernard, et al.. (2016). Recommandations pour la prise en charge buccodentaire des patients atteints de maladies bulleuses auto-immunes avec atteinte buccale. Annales de Dermatologie et de Vénéréologie. 144(3). 182–190. 3 indexed citations
11.
Roux‐Villet, C. Le, Pascale Loiseau, Marc Busson, et al.. (2011). Black Patients of African Descent and HLA-DRB1*15:03 Frequency Overrepresented in Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 131(12). 2386–2393. 57 indexed citations
12.
Prost‐Squarcioni, C., S. Oro, P. Joly, Philippe Bernard, & C. Bédane. (2011). Recommandations des centres de référence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge de l’épidermolyse bulleuse acquise. Annales de Dermatologie et de Vénéréologie. 138(3). 274–279. 5 indexed citations
13.
Roux‐Villet, C. Le, et al.. (2010). Rôle infirmier dans la prise en charge de la pemphigoïde bulleuse. La Revue de l Infirmière. 38–40. 2 indexed citations
14.
Pendaries, Valérie, Matthias Titeux, Catherine Leroux, et al.. (2010). Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. Gene Therapy. 17(7). 930–937. 28 indexed citations
15.
Ammoury, Alfred, C. Paul, C. Prost‐Squarcioni, et al.. (2008). Photodistribution of Blue-Gray Hyperpigmentation After Amiodarone Treatment. Archives of Dermatology. 144(1). 92–6. 25 indexed citations
16.
Doan, Serge, et al.. (2006). Rituximab in Severe Ocular Cicatricial Pemphigoid. Investigative Ophthalmology & Visual Science. 47(13). 594–594. 1 indexed citations
17.
Titeux, Matthias, José Enrique Mejía, Sylvie Bourthoumieu, et al.. (2006). Recessive dystrophic epidermolysis bullosa caused by COL7A1 hemizygosity and a missense mutation with complex effects on splicing. Human Mutation. 27(3). 291–292. 12 indexed citations
18.
Alexandre, M., Marie-Dominique Brette, Francis Pascal, et al.. (2006). A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid. Medicine. 85(4). 239–252. 42 indexed citations
19.
Geneviève, David, Delphine Héron, Vincent El Ghouzzi, et al.. (2005). Exclusion of the dymeclin and PAPSS2 genes in a novel form of spondyloepimetaphyseal dysplasia and mental retardation. European Journal of Human Genetics. 13(5). 541–546. 7 indexed citations
20.
Spirito, Flavia, Stéphane Chavanas, C. Prost‐Squarcioni, et al.. (2001). Reduced Expression of the Epithelial Adhesion Ligand Laminin 5 in the Skin Causes Intradermal Tissue Separation. Journal of Biological Chemistry. 276(22). 18828–18835. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hironori Niizeki Breakdown of academic impact, for papers by Johannes S. Kern Breakdown of academic impact, for papers by Fabienne Jaunin Breakdown of academic impact, for papers by Ken Ishii Breakdown of academic impact, for papers by Dimitra Kiritsi Breakdown of academic impact, for papers by John R. Schiltz Breakdown of academic impact, for papers by Sho Hiroyasu Breakdown of academic impact, for papers by Tiago R. Matos Breakdown of academic impact, for papers by Ramzy S. Labib Breakdown of academic impact, for papers by A M Irani
Rankless by CCL
2026